Alina Tscherne

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

B. Bošnjak, G. Sutter, B. Haagmans, 2021, Proceedings of the National Academy of Sciences.

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents

B. Bošnjak, W. Baumgärtner, G. Sutter, 2021, Frontiers in Immunology.

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice

J. Rojas, S. Adam-Neumair, A. Volz, 2023, Pathogens.

Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19

A. Volz, F. Armando, Sabrina Clever, 2024, Vaccines.

Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection

G. Rimmelzwaan, T. Gerlach, C. K. Prajeeth, 2024, Vaccines.

Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

M. Addo, G. Sutter, B. Haagmans, 2022, Nature Communications.

Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study

A. Volz, R. Fux, S. Jany, 2024, International Journal of Molecular Sciences.